EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
|
EQS-News: Redcare Pharmacy N.V.
/ Key word(s): Miscellaneous/Product Launch
Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
Sevenum, the Netherlands, 06 May 2024. Today, Redcare Pharmacy launched its eHealth-CardLink solution. From now on, all people with statutory health insurance in Germany have full digital access to prescription medicines via the Shop Apotheke app. This innovative function offers significant advantages for customers nationwide. By simply using the health insurance card (eGK) and a smartphone, e-prescriptions can now be redeemed from anywhere and at any time through the app. Olaf Heinrich, CEO of Redcare Pharmacy, comments: “With the launch of our eHealth-CardLink solution, patients can now optimally benefit from the convenience of a paperless, fully digitised prescription. This marks another important step in the digital transformation of the healthcare landscape, offering our company substantial opportunities to further grow in the future.” Redcare Pharmacy’s eHealth-CardLink solution is an additional method for redeeming e-prescriptions. Customers of Shop Apotheke in Germany will still retain the option to use the gematik app or scan the QR code on their printed prescription.
____ Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven. As the one-stop pharmacy of the future, Redcare Pharmacy offers over 11 million active customers a wide range of more than 150,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management. Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.
06.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1896301 |
| End of News | EQS News Service |
|
|
1896301 06.05.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 968,06 | 1.060,32 | 1.204,35 | 1.798,76 | 2.370,58 | 2.940,90 | 3.353,00 | |
| EBITDA1,2 | 15,20 | -38,73 | -29,66 | 39,99 | 29,23 | 47,40 | 77,00 | |
| EBITDA-Margin3 | 1,57 | -3,65 | -2,46 | 2,22 | 1,23 | 1,61 | 2,30 | |
| EBIT1,4 | -0,87 | -65,70 | -69,17 | -17,30 | -38,99 | -28,50 | 9,00 | |
| EBIT-Margin5 | -0,09 | -6,20 | -5,74 | -0,96 | -1,65 | -0,97 | 0,27 | |
| Net Profit (Loss)1 | -16,77 | -74,19 | -77,65 | -11,61 | -46,36 | -39,40 | -15,00 | |
| Net-Margin6 | -1,73 | -7,00 | -6,45 | -0,65 | -1,96 | -1,34 | -0,45 | |
| Cashflow1,7 | 17,80 | 11,64 | -29,11 | 61,46 | 22,13 | 31,00 | 39,00 | |
| Earnings per share8 | -1,17 | -4,15 | -4,32 | -0,73 | -2,27 | -1,87 | -0,73 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Forvis Mazars
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Redcare Pharmacy | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2AR94 | NL0012044747 | N.V. | 770,87 Mio € | 13.10.2016 | Halten | 9F3893WC+F5 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 22,70 | 0,00 | 0,00 | -19,99 | 1,68 | 24,87 | 0,26 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 15.04.2026 | 06.05.2026 | 29.07.2026 | 29.10.2026 | 04.03.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -31,43% | -48,59% | -43,11% | -69,74% | +33,79% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
